Table 4.
Mortality, Hospitalizations, and Nonfatal Grade ≥3 Adverse Events by Human Immunodeficiency Virus Status
| Clinical Outcome | Living With HIV n = 127 |
Not Living With HIV n = 1077 |
Adjusted Hazard Ratioa (95% CI) |
|---|---|---|---|
| Tuberculosis treatment outcome | |||
| Unfavorable | 24 (18.9) | 69 (6.4) | 2.4 (1.3 to 4.2) |
| Favorable | 103 (81.1) | 1008 (93.6) | … |
| Mortality | |||
| Dead | 13 (10.2) | 18 (1.7) | 2.6 (1.2 to 5.8) |
| Alive | 114 (89.8) | 1059 (98.3) | |
| Adjusted Odds Ratiob (95% CI) | |||
| Hospitalization | |||
| Yes | 18 (14.2) | 95 (8.8) | 2.4 (1.3 to 4.6) |
| No | 109 (85.8) | 982 (91.2) | … |
| Adverse event (grade ≥3) | |||
| Yes | 24 (18.9) | 71 (6.6) | 4.4 (2.3 to 8.5) |
| No | 103 (81.1) | 982 (93.4) | … |
Abbreviations: CI, confidence interval; HIV, human immunodeficiency virus.
aAdjusted for age, hemoglobin count, weight-for-age z score, bacteriological confirmation, country, and randomized tuberculosis (TB) treatment duration.
bAdjusted for age, weight-for-age z score, bacteriological confirmation, site of TB disease, hemoglobin count, country, and randomized TB treatment duration.